(Q38252687)

English

Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

title

Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies (English)

1 reference

stated in

Europe PubMed Central

1 September 2017

2

1 reference

stated in

Europe PubMed Central

1 September 2017

Chong Sun

1

0 references

language of work or name

1 reference

16 September 2014

1 reference

stated in

Europe PubMed Central

1 September 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Trends in Biochemical Sciences

1 reference

stated in

Europe PubMed Central

1 September 2017

39

1 reference

stated in

Europe PubMed Central

1 September 2017

10

1 reference

stated in

Europe PubMed Central

1 September 2017

465-474

1 reference

stated in

Europe PubMed Central

1 September 2017

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE11156

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2009.11.022

Identifiers

DOI

10.1016/J.TIBS.2014.08.010

1 reference

stated in

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

PubMed ID

25239057

retrieved

1 September 2017

(Q38252687)

Feedback and redundancy in receptor tyrosine kinase signaling: relevance to cancer therapies

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)